Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 6, Issue 11 (2017)

Resealed erythrocytes: A novel carrier

Author(s):
Supriya Pathak, Manoj Kumar Mishra, Md. Amman Maqbool, Adarsh Kesharwani and Anuradha Kesharwani
Abstract:
Carrier erythrocytes have been evaluated in thousands of drug administration in humans proving safety and efficacy of the treatments. Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents. Erythrocytes mediated drug delivery has been reported with therapeutic enzymes and antiviral agents to maximize therapeutic performance, reduce the side effects, as circulating depots for controlled drug release, drug targeting, treatment of parasitic diseases, hepatic tumors, removal of toxic agents etc. Resealed Erythrocytes are biocompatible, biodegradable, possess long circulation half-life and can be loaded with variety of active drug substances.
Pages: 330-333  |  911 Views  97 Downloads


The Pharma Innovation Journal
How to cite this article:
Supriya Pathak, Manoj Kumar Mishra, Md. Amman Maqbool, Adarsh Kesharwani, Anuradha Kesharwani. Resealed erythrocytes: A novel carrier. Pharma Innovation 2017;6(11):330-333.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal